We have identified a gene encoding a new member of the Caenorhabditis elegans GATA transcription factor family, elt-3. The predicted ELT-3 polypeptide contains a single GATA-type zinc finger (C-X 2 -C-X 17 -C-X 2 -C) along with a conserved adjacent basic region. elt-3 mRNA is present in all stages of C. elegans development but is most abundant in embryos. Reporter gene analysis and antibody staining show that elt-3 is first expressed in the dorsal and ventral hypodermal cells, and in hypodermal cells of the head and tail, immediately after the final embryonic cell division that gives rise to these cells. No expression is seen in the lateral hypodermal (seam) cells. elt-3 expression is maintained at a constant level in the epidermis until the 2½-fold stage of development, after which reporter gene expression declines to a low level and endogenous protein can no longer be detected by specific antibody. A second phase of elt-3 expression in cells immediately anterior and posterior to the gut begins in pretzel-stage embryos. elt-1 and lin-26 are two genes known to be important in specification and maintenance of hypodermal cell fates. We have found that elt-1 is required for the formation of most, but not all, elt-3-expressing cells. In contrast, lin-26 function does not appear necessary for elt-3 expression. Finally, we have characterised the candidate homologue of elt-3 in the nematode Caenorhabditis briggsae. Many features of the elt-3 genomic and transcript structure are conserved between the two species, suggesting that elt-3 is likely to perform an evolutionarily significant function during development.
INTRODUCTION
The Caenorhabditis elegans epidermis (traditionally referred to as the hypodermis) is the tissue primarily responsible for determining the organism's shape. During morphogenesis, changes in hypodermal cell shape drive elongation of the spheroidal embryo into a long thin worm (Priess and Hirsh, 1986) . The hypodermis also synthesises and secretes the collagenous exoskeleton, the cuticle, which maintains the shape of the worm throughout subsequent development. We are interested in understanding the gene regulation that underlies both of these processes.
A number of maternally expressed genes control the early asymmetric cell divisions of the C. elegans embryo, giving rise to the founder cells AB, E, MS, C, D, and P4, each of which goes on to produce a specific set of cell types (Schnabel and Priess, 1997; Bowerman, 1998) . Hypodermal cells are derived from two of these founder cells, AB and C; maternally expressed genes that are necessary to specify the fate of AB and C are, as a result, also required for the production of hypodermal cells. However, little is known regarding the molecular mechanisms by which hypodermal cell types are generated from these founder cells. At the moment, only two zygotic genes, elt-1 and lin-26, have been shown to be involved in the specification and/or maintenance of hypodermal cell fates in the C. elegans embryo (Labouesse et al., 1996; Page et al., 1997) . The elt-1 gene encodes a GATA-type transcription factor that is involved in the specification of hypodermal cell fates (Page et al., 1997) . In elt-1 mutant embryos, hypodermal precursor cells appear to undergo a change in fate to nonhypodermal cell types such as neuron or muscle cells. The lin-26 gene encodes a putative transcription factor containing multiple Cys/His-type zinc fingers and appears to be involved in the maintenance of all nonneuronal ectodermal cell fates (Labouesse et al., 1994 (Labouesse et al., , 1996 . In lin-26 mutant embryos, hypodermal cells either degenerate or, more rarely, express neuronal cell fates. At present, the mechanisms by which these two genes function are unknown, as are the identities of the genes they regulate.
Since the GATA-type transcription factor elt-1 has been shown to be necessary for the early specification of hypodermal cell fates, it seemed possible that additional GATA factors might function later in hypodermal development. This possibility is suggested from work on both vertebrates and C. elegans showing that multiple GATA factors are often involved in the control of differentiation and lineagespecific gene expression of a single tissue type. In vertebrates, differentiation of specific haematopoietic cell lineages involves GATA-1, -2, and -3 (Orkin, 1995) and cardiac and gut development involves GATA-4, -5, and -6 (Jiang and Evans, 1996; Kuo et al., 1997; Molkentin et al., 1997) . Development of the C. elegans endoderm involves at least three GATA factors: elt-2, end-1, and end-3 (Hawkins and McGhee, 1995; Zhu et al., 1997; Fukushige et al., 1998; Joel Rothman, personal communication) . It has previously been shown that expression of the cuticle collagen gene dpy-7 may depend on a GATA binding site (Gilleard et al., 1997) . Since ELT-1 is not present in hypodermal cells at the time of dpy-7 expression (Page et al., 1997; Gilleard et al., 1997) , the presence of at least one other hypodermal GATA factor besides elt-1 is implied.
In this paper, we report the cloning and characterisation of a gene encoding a new hypodermally expressed GATA factor that we have named elt-3. We show that, with the exception of the lateral (seam) cells and a few specialised hypodermal cells in the head, elt-3 is expressed in all hypodermal cells immediately after their birth in the embryo. The possible roles of elt-3 in the regulation of hypodermal development and function are discussed.
MATERIALS AND METHODS

Molecular Biology
Cloning the C. elegans elt-3 gene. cDNA synthesis and RT-PCR were performed as previously described (Johnstone and Barry, 1996; Larminie and Johnstone, 1996) . Two nested degenerate antisense primers corresponding to conserved regions of vertebrate and invertebrate GATA factor DNA binding domains were synthesised and used in conjunction with the SL1 primer (5ЈGGTTTA-ATTACCCAAGTTTGAG3Ј) (Krause and Hirsh, 1987) for consecutive rounds of PCR using mixed-stage cDNA as template. . PCR was  performed for 35 cycles of 94°C for 30 s, 48°C for 1 min, and 72°C for 2 min; the products of the first round of PCR were diluted 1000-fold before being used as template for the second round of PCR. A 600-bp PCR product was subcloned into the pTAG vector (Novagen, Inc.) and sequenced to reveal a new GATA zinc finger gene. The cloned fragment was labelled with [␣- 32 P]dCTP by random priming and used to screen 200,000 pfu of a Lambda ZAP mixed-stage cDNA library, kindly supplied by Dr. R. Barstead (Barstead and Waterston, 1989) . Hybridisation was performed overnight at 65°C in 6ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-5ϫ Denhardt's solution-0.1% SDS-100 g/ml sonicated herring sperm DNA. The final wash was with 0.1ϫ SSC-0.1% SDS at 65°C. Six hybridising clones were isolated and the inserts of the rescued pBluescript plasmids were sequenced. Five of these clones were identical, including their 5Ј end points and numbers of A's in the poly(A) tail, suggesting that they may have originated from a single clone during secondary amplification of the original library. This cDNA, designated transcript A, consists of 1253 bp excluding the poly(A) tail (Fig. 1) . A single cDNA clone, designated transcript B, differed from the five identical transcript A clones by the presence of an additional 6 nucleotides (CTCAAG) following base 126 of the transcript A sequence. This insertion likely derives from an alternative splicing event at the first intron as will be described under Results. The single transcript B cDNA clone ends at base 988 of the transcript A sequence (Fig. 1) . For the following reasons, we believe this truncation reflects mispriming of the oligo(dT) primer during construction of the cDNA library: (i) the truncation site corresponds to a region of the elt-3 sequence that is particularly rich in A residues (18 of 24 residues are A), (ii) the major amplified product of 3Ј RACE experiments (Frohman et al., 1988) has a polyadenylation site corresponding to the position of that in transcript A and no products were amplified that corresponded to polyadenylation at base 988, and (iii) no signal corresponding to a smaller transcript is seen on Northern blots (see Fig. 3 below) .
RT-PCR (Larminie and Johnstone, 1996) was performed on mixed-stage RNA to amplify the 5Ј end of the elt-3 transcript and to determine the relative abundance of transcripts A and B. Primer elt3/5 (5ЈAGTTTGACATTGTTGTGTATG3Ј), an antisense primer internal to the gene, was used in conjunction with either SL1 primer (5ЈGGTTTAATTACCCAAGTTTGAG3Ј) or SL2 primer (5ЈGGTTTTAACCCAGTTACTCAAG3Ј) (Spieth et al., 1993) . The 470-bp PCR product obtained with elt3/5 and SL1 primers was subcloned into the pTAG vector (Novagen, Inc).
Isolation of a C. briggsae elt-3 genomic clone. A radiolabelled probe, corresponding to the first 450 bp of the C. elegans elt-3 cDNA, hybridised only to elt-3 fragments on Southern blots of C. elegans genomic DNA washed at a final stringency of 55°C and 2ϫ SSC. With Southern blots of C. briggsae genomic DNA, the hybridisation pattern produced by this same probe at the same stringency was consistent with the detection of a single-copy C. briggsae elt-3 gene (data not shown). The same probe and hybridisation conditions were used to screen 300,000 pfu of a C. briggsae genomic library ( Charon 4, kindly supplied by D. Baillie and T. Snutch) and a single positive phage clone was isolated. A hybridising 5-kb ClaI/EcoRI fragment was subcloned into pBluescript SK(Ϫ) and sequenced on both strands. The genomic C. briggsae elt-3 clone did not include the expected polyadenylation site and so the C. briggsae elt-3 cDNA was amplified using a 3Ј RACE procedure (Frohman et al., 1988) . cDNA and genomic sequences were compared to determine intron/exon structure.
Northern blotting and RT-PCR. Total RNA was prepared from mixed-staged populations of C. elegans (Wood, 1988) and poly(A) ϩ RNA isolated using the Poly (A) Quik mRNA purification kit (Stratagene). For Northern blots, 10 g of total RNA or 1 g of poly(A) ϩ RNA was electrophoresed on a 1% agarose/formaldehyde gel and blotted and probed as described by Sambrook et al. (1989) . The blots were probed with a 315-bp fragment, amplified by PCR from elt-3 cDNA with primers elt3/7 (ACGATGAACGATTATC-GAGTGG) and elt3/5 (AGTTTGACATTGTTGTGTATG), and radiolabelled by random priming. In order to estimate the loading of each sample, Northern blots were also probed with a fragment of cDNA encoding the constitutively expressed C. elegans eIF-4A-like gene (Roussell and Bennett, 1992) . Semiquantitative RT-PCR was performed precisely as described by Larminie and Johnstone (1996) . Primers specific for the constitutively expressed gene ama-1 were included in each RT-PCR to serve as an internal control (Larminie and Johnstone, 1996) .
Construction of elt-3 reporter genes. Fragment F1 (Fig. 3 , below) was amplified by PCR from cosmid K02B9, using primers elt3/10 (ACGTCTGCAGCATCCACAATAATTGAAAGC) and elt3/1 (ATCTTTTCTAAGAGACAGTGGACG) and cloned into the C. elegans expression vectors pPD22-11 (Fire et al., 1990 ) and pPD95-07 (A. Fire, J. Ahnn, G. Seydoux, and S. Xu, personal communication) following digestion with PstI and SmaI. Fragment F2, generated by digestion of fragment F1 with SalI, was cloned into the SalI/SmaI sites of vectors pPD22-11 (Fire et al., 1990) and pPD95-07 and pPD95-70 (A. Fire, J. Ahnn, G. Seydoux, and S. Xu, personal communication) . Fragment F3 was generated by a SalI/ BalI digestion of fragment F1 and cloned into the corresponding sites of vector pPD95-79. The GFP in-frame insertion construct (F4 on Fig. 3 ) was made as follows: a 5952-bp SalI/StuI genomic fragment encompassing the elt-3 gene was excised from cosmid K02B9 and cloned into pBluescript SK(Ϫ). The resulting plasmid was linearised with MscII, and the GFP coding sequence, which had been excised with Ecl136II from plasmid pPD119-16 (A. Fire, J. Ahnn, G. Seydoux, and S. Xu, personal communication), was cloned into this MscII site creating an in-frame insertion.
C. elegans transformation. The reporter gene constructs were injected into N2 hermaphrodites together with plasmid pRF4 as a visible transformation marker (Mello et al., 1991) ; at least three (usually more) transgenic lines carrying extrachromosomal arrays were generated for each construct. To establish that the observed expression pattern was not influenced by regulatory sequences of the cotransformed pRF4 plasmid (which encodes a mutant collagen gene), constructs containing fragment F2 were also injected into lin-15(n765ts) hermaphrodites together with the rescuing plasmid pL15EK (kindly supplied by Michael Koelle); at least two independent transgenic lines carrying extrachromosomal arrays were examined for each construct. In addition, fragment F2 in vector pPD95-67 was injected by itself into N2 hermaphrodites and the F1 progeny were examined. In all cases, the identical expression pattern was produced. A strain was also produced in which an extrachromosomal array containing fragment F2 in pPD95-67 was randomly integrated into the X chromosome by ␥ irradiation (Egan et al., 1995) . Chromosomal integration reduced the mosaicism of the expression pattern and allowed a more accurate analysis of the time of onset of reporter gene expression.
ELT-3 antibody production and immunostaining. A 722-bp fragment, amplified by PCR from elt-3 cDNA using primers elt3/8b (ACTGCCCGGGAAGGACTCTCAACTTTCCGTGA) and elt3/9 (TCGAAAGCTTGGGAAATTAGACAACTAAAATTGC), was digested with SmaI and HindIII and cloned into the polylinker of the "6ϫ His-tag" expression vector PQE32 (Qiagen). An 824-bp fragment was amplified from elt-3 cDNA using primers elt3/8b and elt3/4 (TAGGTATCAAGTTTCAGTCGTG), digested with SmaI and EcoRI, and cloned into the polylinker of the GST expression vector pGEX3X (Pharmacia Biotechnology). In these two constructs, the ELT-3 polypeptide, from the second amino acid to the stop codon, is fused at its N-terminus to the 6ϫ His-tag or to GST, respectively. Expression of 6ϫ His-tag/ELT-3 fusion protein was induced and then purified using a nickel-agarose affinity column following the manufacturer's instructions. After further purification by SDS-PAGE, the fusion protein was used to immunise rabbits following standard procedures (Harlow and Lane, 1988) . The GST/ELT-3 fusion protein was purified from bacteria as inclusion bodies (Way et al., 1990) , electrophoresed, and transferred onto a nitrocellulose membrane and used to affinity purify ELT-3-specific antibodies (Harlow and Lane, 1988) .
Immunostaining was performed on embryos as described by Miller and Shakes (1995) and on postembryonic stages as described by Finney and Ruvkun (1990) . Briefly, affinity-purified anti-ELT-3 antibodies (at a 1:2 to 1:5 dilution) were incubated with fixed embryos overnight, washed, and incubated with Cy3-labelled donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories) secondary antibody (1:100 dilution) for 2 h at room temperature, followed by extensive washing. When used for immunofluorescence, the affinity-purified ELT-3 antiserum appears to be specific for the endogenous ELT-3 protein based on the following criteria. First, a GST/ELT-3 fusion protein was used to affinity purify antibodies from antisera raised against a 6ϫ His-Tag/ELT-3 fusion protein. Second, immunofluorescence staining was eliminated by preincubation of this purified antibody with GST/ELT-3 fusion protein but not by preincubation with an unrelated GST fusion protein. Third, a strain overexpressing ELT-3 from extrachromosomal arrays showed intense staining in the expected proportion of embryos and in the expected pattern. Fourth, the tissue distribution of antibody staining precisely matches that of the elt-3 reporter genes. The only exception to this last statement is that antibody staining is seen in the lumen of the pharynx between the pharyngeal bulbs of postembryonic stages. We believe this is due to a cross-reactive epitope on an unrelated molecule, since no pharyngeal expression is seen with elt-3 reporter genes and a transcription factor would not be expected to be present in the pharyngeal lumen.
RESULTS
Cloning and Characterisation of the elt-3 Gene
The elt-3 gene was cloned by PCR using degenerate primers as described under Materials and Methods. As shown in Fig. 1A , an ORF beginning at the most 5Ј ATG encodes a predicted polypeptide that includes a single GATA-type zinc finger (C-X 2 -C-X 17 -C-X 2 -C) with an adjacent basic region, characteristics of the DNA binding domain of the GATA transcription factor family (Fig. 1B) . The gene was named elt-3 following nomenclature established with the previously identified C. elegans GATA factors elt-1 and elt-2 (Eryf1-like transcription factor) ( Spieth et al., 1991; Hawkins and McGhee, 1995) .
The elt-3 gene produces two alternative transcripts: transcript B differs from transcript A by the insertion of 6 nucleotides (CTCAAG) following base pair 126. As shown in Fig. 1 , this insertion replaces a C residue with the residues SQG near the N-terminus of the predicted polypeptide. This 6-bp insertion occurs at the first intron junction and apparently results from a splicing event in which an alternative 3Ј splice acceptor site is utilised (see Fig. 7D below). To determine the relative abundance of transcripts A and B, we amplified the 5Ј end of the elt-3 transcript by PCR from mixed-stage cDNA using the SL1 primer and primer elt3/5 (an antisense primer corresponding to sequence in the fourth exon). One band of approximately 470 bp in length was amplified and cloned. Of 15 plasmid inserts sequenced, 9 corresponded to the type A transcript and 6 corresponded to the type B transcript. This RT-PCR experiment was repeated and of 10 cloned inserts, 6 corresponded to transcript A and 4 to transcript B. We conclude that transcripts A and B are of approximately equal abundance in mixed-stage RNA. All amplified products were SL1 trans-spliced at the same position; no amplification product was obtained when an SL2 primer was used in conjunction with the elt3/5 primer (data not shown).
After we had identified the elt-3 cDNAs, the C. elegans genome consortium sequenced the corresponding genomic locus, which lies on the right arm of the X chromosome (cosmid K02B9). When C. elegans genomic Southern blots are probed at high stringency (65°C, 0.1ϫ SSC) with a full-length elt-3 cDNA probe, only bands corresponding to this locus are detected (data not shown). Comparison of genomic and cDNA sequence shows the gene to contain five introns, ranging in size from 46 to 459 bp, all of which are bounded by consensus splice donor and splice acceptor sequences. A predicted splice acceptor site (TTGCAG) corresponds to the SL1 splice site determined by RT-PCR. One noteworthy feature of the elt-3 genomic sequence is the presence of nine WGATAR sites (seven of which are TGATAA) in the 5Ј flanking region; seven of the nine sites cluster between 1328 and 1093 bp upstream of the transsplice acceptor site. Similar clusters of WGATAR sites have been noted upstream of both elt-1 (Spieth et al., 1991) and elt-2 (Hawkins and McGhee, 1995) . Hence it is possible that elt-3 is involved in autoregulation and/or cross regulation between different GATA factors. Autoregulation of elt-2 has been demonstrated experimentally .
As noted above, the predicted ELT-3 polypeptide contains a single (C-X 2 -C-X 17 -C-X 2 -C)-type zinc finger and an adjacent basic region that defines the DNA binding domain of the GATA transcription factor family (Orkin, 1995) . Figure  1B shows a comparison between the ELT-3 polypeptide sequence and a number of selected invertebrate and vertebrate GATA factors. The ELT-3 DNA binding domain is marginally more similar to GATA factors expressed in the C. elegans or Drosophila ectoderm (elt-1, 30/50 residues ϭ 60% identity, and pannier, 29/50 residues ϭ 58% identity) than it is to those expressed in endoderm (elt-2, 27/51 residues ϭ 53% identity, and serpent, 27/50 residues ϭ 54% identity). However, the significance of such small differences is questionable. The C. elegans genome sequencing consortium has recently identified a number of new sequences that fit the GATA zinc finger consensus. With the genome sequence essentially completed (and providing these new sequences turn out to encode transcribed genes), the C. elegans GATA factor family consists of at least 10 members. None of the new GATA zinc fingers appear to be significantly more closely related to that of ELT-3 than any of the others (data not shown).
There are two consensus nuclear localisation signals (NLS) in the ELT-3 polypeptide (identified by PSORT (Nakai and Kanehisa, 1992)); one resides within the DNA binding domain (residues 187-204) and is a bipartite NLS as first described in Xenopus by Robbins et al. (1991) . The second NLS (PMKKRMA) lies between residues 137 and 143 and is of a type found in the SV40 large T antigen (Hicks and Raikhel, 1995) . One unusual feature of the ELT-3 polypeptide is that it terminates shortly after the DNA binding domain, whereas all previously described GATA factors have a C-terminal extension. Indeed, a transcriptional activation domain has been mapped to the C-terminal domain of the ELT-1 polypeptide (Shim et al., 1995) .
elt-3 mRNA Abundance during C. elegans Development
Total RNA was prepared from mixed-stage animals, embryos, and L4 larvae and probed on a Northern blot with a radiolabelled fragment corresponding to the full-length elt-3 cDNA ( Fig. 2A) . In each RNA sample, a single band of approximately 1.3 kb was detected, consistent with the size predicted from the cDNA data presented above. The message is of much higher abundance in embryo RNA than in mixedstage or L4 RNA. Semiquantitative RT-PCR was performed on RNA prepared from L1, L2, L3, L4, and immature adult stages using the method described by Johnstone and Barry (1996) and Larminie and Johnstone (1996) . elt-3 transcripts appear to be present at approximately the same abundance in each of the five postembryonic developmental stages (Fig. 2B ). Johnstone and Barry (1996) demonstrated that cuticle collagen mRNA oscillates throughout postembryonic development, peaking once during each larval stage. Using the same semiquantitative PCR method on the same RNA samples, elt-3 mRNA showed no such oscillation (data not shown; RNA kindly supplied by Iain Johnstone).
Expression Pattern of elt-3 Reporter Genes
In order to determine the elt-3 expression pattern, a number of different elt-3 genomic fragments were cloned (Roussell and Bennett,1992) . (B) Postembryonic stage-specific RT-PCR: PCR was performed using elt-3 and ama-1 gene-specific primers on cDNA synthesised from RNA isolated from specific C. elegans developmental stages L1, L2, L3, L4, and immature adult (Ad). The PCR products were separated on a 2% agarose gel, Southern blotted, and probed with an elt-3-specific probe. Following autoradiography, the blot was stripped and reprobed with an ama-1-specific probe. The two autoradiographs are shown superimposed with the elt-3 and ama-1 products indicated. Genomic and cDNA products for ama-1 can be distinguished by the product size due to the presence of an intron between the primer sites. No genomic product was amplified for elt-3 since one PCR primer corresponded to the SL1 trans-spliced leader.
into a variety of C. elegans reporter gene vectors (Fig. 3 and Materials and Methods). Genomic fragments F1 and F2 were used to produce translational fusions within the last exon of elt-3 and included all the elt-3 intronic sequences as well as 4494 and 1853 bp of 5Ј flanking sequence, respectively. F1 and F2 were cloned into several C. elegans expression vectors encoding either ␤-galactosidase or GFP reporter genes containing an SV40 nuclear localisation signal at the N-terminus. The nuclear localisation of these reporter molecules aids in the identification of specific cells.
Reporter gene expression is first detected in eight nuclei on the posterior dorsal surface of the embryo, corresponding to the position of the granddaughters of Cpaa and Caaa (Fig.  4A) . The time of onset of elt-3 reporter gene expression was approximately 240 min after the first cell cleavage (embryos allowed to develop at 20°C), which corresponds to the time immediately after the cell division that gives rise to these cells. At approximately 260 min after the first cleavage, reporter gene expression is now also detected in nuclei on the dorsal surface of the embryo, corresponding to the position of the major hypodermal cells, and in six nuclei on each ventrolateral aspect of the embryo, corresponding to the position of the ventral hypodermal cells (P cells) (Figs. 4B and 4C) . The identity of all cells expressing the reporter gene construct can be most easily determined in commastage embryos (approx 350 min after first cleavage) (Figs. 4D, 4E, and 4F). At this stage, expression is seen in all the dorsal (hyp-7) and ventral (P1/2-P11/12) hypodermal cells in the main body region; expression is also seen in hypodermal cells of the head (hyp-4, hyp-5, and hyp-6 ) and tail ( hyp-8, hyp-9, hyp-10, and hyp11) (Figs. 4D, 4E , and 4F). No expression is seen in the lateral hypodermal cells (seam cells; V1-V6, H0, H1, H2, and T) or the minor hypodermal cells of the head (hyp-1, hyp-2, and hyp-3). An apparently constant level of expression is maintained in these cells throughout embryonic development up to the 2½-fold stage (Figs. 4G and 4H ). At the 3-fold stage, the level of expression becomes significantly reduced and this reduced level of expression is maintained throughout postembryonic development and in the adult worm.
An additional check was made on the identity of the cells expressing the elt-3 reporter genes by cloning fragment F3 (Fig. 3) into pPD95-77, a vector encoding GFP lacking the SV40 nuclear localisation signal; the accumulation of GFP in the cytoplasm of expressing cells enabled cell shape to be visualised. The expression pattern produced by this construct was entirely consistent with the expression patterns seen with the nuclear-localised constructs. In particular, the absence of expression in the lateral hypodermis is striking. As shown in Figs. 4I and 4J, the lateral hypodermal A later digestive-tract-specific component of the elt-3 expression pattern, produced by all of the above constructs, is seen from the 3-fold stage of embryogenesis onward. Expression is seen in two cells immediately anterior to the gut (Fig. 7L) . As revealed by the non-nuclear-localised reporter gene expression, these cells form a symmetrical ring between the pharynx and the gut (Fig. 4M) and are likely to be the vpi3 cells of the pharyngeal-intestinal valve. elt-3 is also expressed in five cells immediately posterior to the gut. Four of these nuclei form a tight cluster near the region of the anal sphincter and one of the nuclei is slightly more dorsal and posterior in position (Figs. 4K and  4N ). We believe these cells are the intestinal-rectal valve cells (virL and virR) and the rectal epithelial cells (rect D, rect VL, and rect VR) that form the junction between the intestine and the rectum, but definitive identification has not yet been possible.
To determine if the presence of the elt-3 3Ј UTR and flanking sequence influences the expression pattern described above, and to determine the subcellular location of the ELT-3 polypeptide, we produced an in-frame insertion of GFP directly into the second exon of the elt-3 genomic fragment (see Fig. 3 above) . This fragment extended from 1853 bp upstream of the ATG to 2213 bp downstream of the TGA stop codon. The expression pattern produced in three independent transgenic lines was indistinguishable from that previously described. In addition, GFP fluorescence was entirely restricted to cell nuclei, consistent with the predicted role of elt-3 as a transcription factor (data not shown).
Distribution of Endogenous ELT-3 Polypeptide
In general, reporter gene expression patterns in C. elegans accurately reflect expression patterns of the endogenous genes. However, it is not possible to be sure that all regulatory sequences are included in a particular construct and there are a number of examples in which incomplete promoter regions produce ectopic reporter gene expression (Aamodt et al., 1991; Krause et al., 1994; Egan et al., 1995) . Indeed, for the fkh-1/pha-4 gene, inclusion of as much as 7 kb of upstream sequence in reporter gene constructs still does not precisely recapitulate the distribution of endogenous RNA and protein (Azzaria et al., 1996; Kalb et al., 1998) . Hence, to determine the distribution of endogenous ELT-3 protein, we raised polyclonal antisera against the full-length ELT-3 polypeptide expressed in bacterial cells (see Materials and Methods). Antibody staining was first detected at approximately 240 min after first cleavage in the nuclei of the same eight dorsal hypodermal cells that expressed the reporter genes at the same stage of embryogenesis (Fig. 5A) . Similarly, at the lima bean and comma stages, precisely the same cell nuclei that expressed the elt-3 reporter gene constructs also stained with antibody (Figs. 5B, 5C, and 5D) . At all stages, antibody staining was detected in cell nuclei and not in cytoplasm. In contrast to the reporter gene expression, endogenous ELT-3 protein could not be detected in any hypodermal cells at stages later than the 2½-fold stage. It is possible that elt-3 is not expressed in the hypodermis from the 2½-fold stage of embryogenesis onward and that the reporter gene expression seen in the later stages is due to reporter perdurance. Alternatively, it is possible that elt-3 continues to be expressed in the hypodermis of later stages but at levels below that detected by antibody. In situ hybridisation methods are of low sensitivity for late-stage embryos and larvae of C. elegans (Seydoux and Fire, 1995) and consequently are not suitable for resolving this issue. Also, the RT-PCR and Northern blot data of Fig. 2 do not shed light on this matter since neither technique can distinguish between elt-3 expression in the hypodermis and the second phase of elt-3 expression in the digestive tract. Antibody staining detects the second phase of elt-3 expression in cells immediately anterior and posterior to the gut (Fig. 5E ), confirming the reporter gene results shown above.
elt-3 Expression in elt-1 and lin-26 Mutant Embryos
We have examined the expression of elt-3 in embryos mutant for two genes, elt-1 and lin-26, that are known to be required for the specification and/or maintenance of hypodermal cells. Both of these genes are expressed in hypodermal precursor cells prior to elt-3 expression and so lie potentially upstream of elt-3 in the regulatory pathway that controls hypodermal cell development.
The elt-1 gene is necessary for the embryo to produce hypodermal cells from each of the hypodermal precursor blastomeres in the early embryo (Page et al., 1997) . The chromosomally integrated elt-3::GFP transgenic array was crossed into a strain of genotype elt-1(zu180) unc-43(e408)/ unc-24(e1380)dpy-20(e1282) (kindly supplied by B. Page). This strain segregates 25% elt-1(zu180) homozygotes, which arrest without undergoing elongation (Page et al., 1997) . A small number of elt-3::GFP-expressing nuclei (mean 5.1, SD 1.33, N ϭ 39) were visible in elt-1(zu180) homozygous embryos beginning approximately 260 min after the first cell cleavage (Figs. 6A and 6B ). These nuclei were generally smaller than normal hypodermal cells and were always located in the posterior half of the embryo, often at the outer margins. Reporter gene expression is initiated in these cells at precisely the same time of embryogenesis as occurs in hypodermal cells of wild-type embryos. These cells do not represent the second phase of elt-3 expression in cells anterior and posterior to the gut, since this phase does not begin until the pretzel stage (approximately 500 min after first cleavage). Indeed, this second digestive tract phase of elt-3 expression is clearly visible in elt-1(zu180) homozygous embryos examined after 10 h of development (data not shown). In conclusion, elt-1 is required for the production of most elt-3-expressing hypodermal cells in the embryo but a small number of such cells are still produced in the absence of elt-1 function.
The monoclonal antibody MH27 specifically binds to adherens junctions in the cell membranes of hypodermal, gut, and pharyngeal cells (Francis and Waterston, 1985) . Page et al. (1997) observed that a small number of MH27-positive cells, not associated with the gut or pharynx, were present in elt-1 mutant embryos and they speculated that these might be minor hypodermal or neuronal support cells. Our results suggest these are indeed hypodermal-like cells since the elt-3-expressing cells present in elt-1 mutant embryos from 260 min of embryogenesis also express the target epitope of MH27 (Figs. 6C, 6D, and 6E) .
The chromosomally integrated elt-3::GFP array was crossed into a strain of genotype lin-26(mc15) unc-4(e120)/ mnC1 (ML581, kindly supplied by M. Labouesse) (den Boer et al., 1998) . This strain segregates 25% lin-26(mc15) homozygotes that arrest between the comma and the 1½-fold stage of embryogenesis. The elt-3 GFP expression pattern in lin-26(mn15) homozygotes was indistinguishable from that of wild-type embryos up to the 1½-fold stage of embryogenesis (data not shown). The hypodermal expression of elt-3 declined to low levels in mutant embryos after approximately 450 -500 min of development, just as elt-3 expression normally declines in wild-type embryos. Arrested embryos examined after 10 h of development showed expression in nuclei immediately anterior and posterior to the gut; i.e., the second phase of elt-3 expression was also unaffected in the lin-26 null mutant embryos.
The Candidate Homologue of elt-3 in C. briggsae
The evolutionary relation between the two nematode species C. elegans and C. briggsae is such that intergenic and intronic sequences have diverged considerably but, for many genes, coding sequence and regulatory elements have been conserved (Xue et al., 1992; Kennedy et al., 1993; Krause et al., 1994; Gilleard et al., 1997) . Consequently, identification of an elt-3 homologue in C. briggsae would suggest evolutionary constraint and attendant functional significance. In addition, comparative sequence analysis may identify functionally important features of the gene.
A radiolabelled fragment, corresponding to the first 450 bp of the C. elegans elt-3 coding sequence, was used to probe genomic Southern blots of both C. elegans and C. briggsae genomic DNA. At moderate stringency, the probe hybridised to fragments in C. briggsae genomic DNA in a manner consistent with the detection of a single-copy gene while at the same time remaining specific for the C. elegans elt-3 gene (data not shown). This probe was used at the same stringency to isolate a single positive phage clone from a C. briggsae genomic library. A hybridising 5-kb ClaI/EcoRI fragment was subcloned and sequenced. Comparison with the C. elegans elt-3 genomic sequence suggested that the 5-kb C. briggsae genomic fragment extended from 790 bp upstream of the first exon of elt-3 to approximately 114 bp upstream of the 3Ј end of the last exon. To determine the intron/exon structure and to obtain the 3Ј end of the C. briggsae gene, RT-PCR 3Ј RACE (Frohman et al., 1988) was used to amplify a putative full-length cDNA.
As shown in Fig. 7A , the genomic organisation of the C. briggsae gene is similar to that of the C. elegans elt-3 gene. Although the introns are generally larger in the C. briggsae gene, the basic intron/exon structure is conserved between the two species; each of the six exons of the C. elegans gene are easily identified in C. briggsae on the basis of sequence similarity and the precise conservation of splice donor and acceptor site positions. However, the C. briggsae gene contains an additional 54-bp exon (designated 3A) lying between exon 3 and exon 4 of the C. elegans gene (Fig. 7) . Database searching did not identify any significant similarities to the peptide sequence encoded by this exon. The predicted ELT-3 polypeptide is 83.5% identical between the two species and there is 100% identity within the DNA binding domain (Fig. 7B) . Two additional unusual features of the elt-3 transcript are conserved in both species. First, the stop codon follows shortly after the DNA binding domain in both species, i.e., unlike other GATA factors, ELT-3 lacks a C-terminal domain. Second, the elt-3 3ЈUTR is long (488 bp in C. elegans and 608 bp in C. briggsae) and contains a region of approximately 100 bp that is highly conserved between the two species (Fig. 7C) .
We also investigated whether the alternative splicing event that occurs at the 3Ј splice acceptor site of the first intron in the C. elegans gene also occurs in C. briggsae. The genomic sequence of the 3Ј end of the first intron of C. briggsae elt-3 contains a splice acceptor site (ATTACAG) that is utilised in both of the two sequenced C. briggsae cDNA fragments amplified by the 3Ј RACE/RT-PCR and described above (Fig. 7D) . However, the sequence CATGAG occurs just 6 bp upstream of this site; this sequence is not a commonly used 3Ј splice acceptor sequence in C. elegans , but splicing at this sequence would maintain the reading frame. To determine whether this upstream site is utilised, an RT-PCR experiment was performed, similar to that described for the C. elegans gene. Two PCR fragments, independently amplified from mixed-stage cDNA using SL1 and a gene-specific antisense primer, were cloned and 12 plasmid inserts from each cloning were sequenced. All 24 sequences corresponded to the utilisation of the downstream splice acceptor site shown in Fig. 7 and we conclude that the alternative splicing event seen in C. elegans does not occur in C. briggsae. It is not clear if the existence of two alternative elt-3 transcripts in C. elegans is functionally unimportant or reflects some aspect of elt-3 function that differs between the two species.
DISCUSSION
elt-3 Encodes a C. elegans GATA Factor
The C. elegans elt-3 gene encodes a polypeptide that is predicted to belong to the GATA transcription factor family, which functions by binding to cis regulatory elements containing a consensus (A/T)GATA(A/G) sequence (Orkin, 1995) . Endogenous ELT-3 protein is indeed located within hypodermal cell nuclei consistent with a role as a transcriptional regulator. GATA factors regulate diverse sets of genes in a wide range of species including yeast, worms, flies, and vertebrates. Processes regulated by members of this transcription factor family include cellular differentiation and lineage-specific gene expression (GATA-1, 2, and 3) (Orkin, 1995) , cell proliferation (GATA-2) (Tsai et al., 1994; Tsai and Orkin, 1997) , and intercellular signalling during morphogenesis (GATA-4) (Kuo et al., 1997; Molkentin et al., 1997) . Arguing by analogy, a variety of processes could be regulated by elt-3 during hypodermal morphogenesis.
elt-3 Expression Reflects the Difference between Dorsal/Ventral and Lateral (Seam) Hypodermal Cells
elt-3 is expressed in all hypodermal cells except for the seam cells and a few small specialised hypodermal cells of the head. Expression is first detected within a few minutes following the final embryonic cell division that gives rise to hypodermal cells (Fig. 8) . Hence elt-3 could either initiate, or participate in the early stages of, the regulatory cascade controlling the differentiation of these cells. elt-3 expression is maintained at an apparently constant level until the 2½-fold stage of development and so could also regulate genes that are expressed in the hypodermis during elongation and the early phases of cuticle synthesis. The possibility that elt-3 is expressed at a low level in the hypodermis during late embryonic and postembryonic development suggests it may have additional functions later in development. A priority of our future work will be to identify the genes directly regulated by elt-3.
The expression of elt-3 in the dorsal and ventral but not the lateral (seam) hypodermis reflects a fundamental division of hypodermal cell types in C. elegans. The cells of the dorsal and ventral epidermis are structurally and functionally similar to each other but distinct from cells of the lateral hypodermis. During elongation, these two hypodermal cell types show differences in the behaviour and organisation of the microfilament and microtubule components of the cytoskeleton (Priess and Hirsh, 1986) . Two genes proposed to be involved in the regulation of these cytoskeletal changes, the Rho-binding serine/threonine kinase let-502 and the myosin phosphatase regulatory subunit mel-11, also show differential expression between these two hypodermal cell types (Wissmann et al., 1997) . mel-11 is expressed at much higher levels in the dorsal and ventral hypodermis than in the lateral hypodermis, whereas let-502 shows a reciprocal expression pattern (A. Wissman, personal communication). There are also differences in the cuticle secreted by the dorsal and ventral hypodermis and the cuticle secreted by the lateral hypodermis (Singh and Sulston, 1978) . For example the cuticle collagen gene dpy-7 is expressed in the dorsal and ventral but not in the lateral hypodermis (Gilleard et al., 1997) , whereas the col-7 collagen gene is expressed only in the lateral hypodermis (Liu et al., 1995) . Clearly, genes that are expressed in the same (Sulston et al., 1983) . (B) Lineage of one of the major hypodermal precursors (ABpla) that gives rise to hypodermal cells. Lateral seam cells are indicated by "S" and all other hypodermal cell fates are indicated by "H". Lineages that express elt-3 are shown in bold. elt-3 expression initiates immediately after the final cell division that gives rise to hypodermal cells. The time of development after the first cell cleavage (at 20°C) is shown on the vertical axis and the times of onset of elt-1, lin-26, and elt-3 expression are indicated. Cells undergoing programmed cell death are marked "x". Nonhypodermal cell fates are not marked; for the ABarp, Abpra, and ABpla blastomeres, the most common nonhypodermal fate is neuronal, whereas for the C blastomere it is muscle. subset of hypodermal cells as elt-3, such as dpy-7 and mel-11, are candidate targets of elt-3 regulation. Indeed promoter analysis has implicated a GATA site as a dpy-7 control element (Gilleard et al., 1997) .
Interestingly, two other C. elegans GATA factors show differential expression between the dorsal/ventral and lateral hypodermis but their expression patterns are reciprocal to that of elt-3. elt-1, which is initially expressed in all hypodermal progenitor cells, disappears from the dorsal and ventral hypodermal cells shortly after they are born (i.e., at the time that elt-3 expression is initiated) but remains expressed in the lateral hypodermis throughout embryogenesis (Page et al., 1997) . Also, reporter gene analysis of another recently identified C. elegans GATA factor suggests this gene is expressed at much higher levels in the lateral hypodermis than in the dorsal/ventral hypodermis (Joel Rothman, personal communication). Hence these three C. elegans GATA factors may determine, or at least contribute to, the fundamental differences between the dorsal/ventral and the lateral hypodermis.
Regulation of elt-3
The lineage origin of hypodermal cells in the C. elegans embryo is complex (Sulston et al., 1983) . The major hypodermis is derived from four different precursor cells in the 12-cell embryo, each of which also gives rise to a variety of other cell types (Fig. 8) . Little is known about how these complex lineage patterns are established. elt-1 and lin-26 are two genes that are known to be important for hypodermal cell development and consequently could be involved in elt-3 control (Fig. 8) . We have shown that the normal elt-3 expression pattern is established in the absence of lin-26 function. This supports the proposal by Labouesse et al. (1996) that the primary function of lin-26 is the maintenance rather than the specification or differentiation of hypodermal cells; the loss of lin-26 function results in the gradual degeneration of hypodermal cells and only rarely in cell fate transformations.
We have found that elt-1 mutant embryos contain an average of only 5 elt-3-expressing cells compared to the 51 hypodermal cells that express elt-3 in wild-type embryos. This result supports the conclusion of Page et al. (1997) that elt-1 is required for the specification of most, if not all, major hypodermal cells (as defined by Gendreau et al., 1994) . Hence the loss of elt-1 function causes the precursors of most elt-3-expressing hypodermal cells to adopt alternative nonhypodermal cell fates. It is also possible that elt-1 could be a direct positive regulator of elt-3 since elt-1 is a GATA factor and a cluster of GATA binding sites is present upstream of the elt-3 gene. However, we do not believe this to be likely, for the following reasons. First, elt-1 is initially expressed and appears to specify hypodermal cell fates several cell divisions before the onset of elt-3 expression (Fig. 8) (Page et al., 1997) . Second, although elt-1 is expressed in all the major hypodermal precursor cells and is maintained in the lateral hypodermis, its expression disappears in the dorsal and ventral hypodermis shortly after these cells are born; i.e., elt-1 expression is declining in the same cells and at approximately the same time as elt-3 expression is beginning. These latter observations are more consistent with one, or both, of these genes repressing the expression of the other. Indeed, such a relation could account for the observed expression patterns. For example, if elt-1 were a repressor of elt-3, the loss of elt-1 expression in the dorsal and ventral hypodermis but not in the lateral hypodermis would result in the observed elt-3 expression pattern. Conversely, if elt-3 were a repressor of elt-1, initiation of elt-3 expression would downregulate elt-1 expression in the dorsal and ventral but not the lateral hypodermis. The relation between elt-1 and elt-3 can in principle be deciphered by ectopic expression experiments and by examining elt-1 expression in elt-3 mutant embryos.
Although elt-1 is necessary for the majority of cells to express elt-3, an average of five cells express the elt-3::GFP reporter gene in elt-1 mutant embryos. These cells are born at the same time as hypodermal cells in wild-type embryos and also stain with the monoclonal antibody MH27 (a hypodermal, pharynx, and gut cell marker). Hence there appear to be a small number of elt-3-expressing hypodermal cells that are specified in the absence of elt-1 function. Page et al. (1997) described elt-1 as being expressed in all the major hypodermal cells but not in the minor hypodermal cells, as defined by Gendreau et al. (1994) . There are four minor hypodermal cells in the tail region of wild-type embryos that express elt-3 (hyp-8, hyp-9, and 2ϫ hyp-10). Since these cells do not express elt-1 (Page et al., 1997 and Page, personal communication) , they are the most likely candidates for the elt-3-positive cells present in elt-1 mutant embryos. However, the average number of elt-3-positive cells in elt-1 mutant embryos is actually five, not four, and we have seen very occasional embryos with up to nine positive cells (although in these cases the fluorescence is extremely faint for some of the nuclei scored as positive). It is possible that these additional nuclei are a consequence of the severe disruption of morphogenesis in elt-1 mutant embryos; i.e., disruption of cellular interactions could lead to additional tail hypodermal cells being produced. Bowerman et al. (1992) have described an example of such an effect; the production of intestinal valve cells becomes restricted to one of two possible precursor cells by a cellular interaction during morphogenesis. When this interaction is disrupted by blastomere ablation in wild-type embryos or by deranged morphogenesis in lag-2 mutant embryos, twice the normal number of valve cells is produced. Detailed lineage analysis will be necessary to determine if a similar mechanism explains the origin of the additional elt-3-expressing cells in the elt-1 mutant embryos.
We do not yet know if elt-3 is an essential gene or whether it is functionally redundant. We have been unable to produce an obvious phenotype by RNA-mediated interference (Fire et al., 1998) using single-or double-stranded elt-3 RNA (data not shown). We are currently isolating a gene knockout by imprecise transposon excision. One piece of evidence that suggests elt-3 is important to nematode development is the presence of a highly related gene in C. briggsae and the precise conservation of many features of the gene.
